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e-mail addresses: drjaved007@gmail.com, javed@lvpei.org (M.J. Ali).Mohammad Javed Ali, MD, FRCS ⇑; Milind N. Naik, MDAbstractAim: To report the outcomes of endoscopic guided anterograde 3 mm balloon dacryoplasty with silicone intubation in patients
with acquired partial nasolacrimal duct obstructions in adults.
Methods: Retrospective case series, included 21 eyes with partially obstructed nasolacrimal ducts of 12 patients. All the 21 ducts
were initially probed and the probe confirmed with an endoscope in the inferior meatus. After confirming the presence of probe in
the inferior meatus, a 3 mm balloon was used for dilating the distal and proximal portions of nasolacrimal duct, followed by stent-
ing of ducts with Crawford tubes. Main outcome measures were anatomical patency of the passage and resolution of epiphora.
Results: Of the 12 patients, 9 had bilateral and 3 had unilateral acquired partial nasolacrimal duct obstructions. All the patients
underwent bicanalicular stenting under endoscopic guidance which were retained for a period of 12 weeks. A minimum follow
up of 6 months following stent removal was considered for final analysis. 15 of the 21 ducts (71%) were freely patent on irrigation
but 13 of the 21 reported improvement of epiphora. Two nasolacrimal ducts showed similar partial regurgitation and partial
patency on syringing as before with no improvement of symptoms. Four nasolacrimal ducts were completely obstructed with com-
plete regurgitation of fluid on syringing with worsening of the epiphora. Two eyes persisted with symptoms of epiphora despite
patent nasolacrimal duct with grade 2 dye retention on dye disappearance test.
Conclusions: 3 mm balloon dacryoplasty is an alternative and safe way to manage partial nasolacrimal duct obstructions with an
anatomical success in 71% and functional success in 62% of the patients. Further studies with a large sample size and longer follow-
up are required to ascertain the long term benefits.
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Balloon dacryoplasty is a term used for a set of minimally
invasive lacrimal procedures that utilizes specially designed
balloons, targeted at different points in the lacrimal system
for a wide range of indications. Balloons were first used by
Becker and Berry in 1989.1 Around the same time Munk
et al. reported balloon catheter dilatation for adults with
epiphora using an angioplasty catheter under fluoroscopicguidance.2 There are ongoing efforts worldwide to look for
an alternative to dacryocystorhinostomy (DCR) in the man-
agement of nasolacrimal duct obstructions (NLDO). Probing
alone or silicone intubation alone was not found to have
encouraging results in studies that did not differentiate
between complete and partial NLDO.3,4 However bicanalicular
silicone intubation specifically for partial NLDO was found
to have a success rate of 54%.5 Balloon dacyroplasty is also
rapidly gaining ground as a minimally invasive alternativee:
al.com
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The purpose of the present study is to describe the efficacy
and complications of 3 mm balloon catheters in managing
acquired partial or incomplete NDLO in adults.Methods
Retrospective case series included 21 eyes with partially
obstructed nasolacrimal ducts of 12 patients. Partial obstruc-
tion of nasolacrimal ducts was diagnosed by two ways, one a
gentle and slow intra-sac syringing, wherein there was a par-
tial regurgitation of the fluid as well as drainage of fluid into
the nose. Second, a dacryoendoscopy was performed to
ascertain the partial obstruction in the nasolacrimal duct. Pa-
tients with canalicular stenosis or partial canalicular obstruc-
tions and post-traumatic obstructions were excluded. None
of the patients underwent any interventions for epiphora in
the past. Balloon dilatation was performed as per the stan-
dard way published in the literature.6 The nasolacrimal ducts
were initially probed and the probe confirmed in the inferior
meatus with an endoscope. Subsequently the entire proce-
dure was carried out under nasal endoscopic guidance. After
the assembly of the balloon catheter with the inflation device
(Atrion Corporation, Allen, Texas, USA), the 3 mm lubricated
balloon (Fig 1) was then passed through the superior punc-
tum into the distal portions of the nasolacrimal ducts. This
is ascertained by the markings on the catheter (Fig 1) or by
visualizing around half of the length of catheter in the inferior
meatus (Fig 2). The balloon is stabilized in this position and
with the help of manometer device (Fig 3), inflated to 8 atmo-
spheres for 90 s, deflated and reinflated to 8 atmospheres for
60 s (Fig 4). The balloon is then withdrawn into the proximal
portion of the nasolacrimal duct (Fig 5). The position is ascer-
tained by the markings on the catheter or by visualizing just
the tip of the catheter in the inferior meatus (Fig 5). The same
cycle of inflation, deflation and reinflation is repeated again
for the proximal portion of the nasolacrimal duct. The cathe-
ter was then withdrawn and irrigation of the lacrimal system
was performed to assess the patency. This was followed by
stenting of nasolacrimal duct with Crawford bicanalicular
intubation under nasal endoscopic guidance (Fig 6). A wellFigure 1. Distal end of a 3 mm balloon catheter with the balloon and its
markings.dilated nasolacrimal duct opening is noticed at the end of
the procedure (Fig 6). Post-operatively the patients received
topical antibiotic–steroid eye drops in a tapering dose for
2 weeks. Data collected include demographic data, clinical
presentation, laterality, status of lids and puncta, irrigation
findings, probing interpretations, and duration of intubation.
Anatomical success was defined as patency of the lacrimal
passage on irrigation and functional success was defined as
resolution of epiphora.Results
There were 4 male and 8 female patients. Mean age was
58.2 years (range 42–71 years). Of the 12 patients 9 had bilat-
eral and 3 had unilateral partial nasolacrimal duct obstruc-
tions. All the patients underwent bicanalicular stenting
under endoscopic guidance. All stents were retained for a
period of 12 weeks. No significant complications were no-
ticed. All patients reported occasional blood tinged nasal
secretions in the first week following the procedure. Two pa-
tients reported infrequent irritation and discomfort due to
stent. A minimum follow up of 6 months following stent re-
moval was considered for final analysis. At the final follow
up, 15 of the 21 ducts (71%) were freely patent on syringing
and reported improvement of epiphora. Two nasolacrimal
ducts (9.5%) showed similar partial regurgitation and partial
patency on syringing as before with no improvement of
symptoms. Four nasolacrimal ducts (19%) were completely
obstructed with complete regurgitation of fluid on syringing
and worsening of the epiphora. Two eyes persisted with
symptoms of epiphora despite patent nasolacrimal duct with
grade 2 dye retention on dye disappearance test. The
anatomical success was 71% and the functional success rate
was 62%.Discussion
Dacryocystorhinostomy (DCR) has been the common
modality of treatment of symptomatic partial NLDO in adults.
External as well as endoscopic approaches for DCR has highFigure 2. Endoscopic view of the inferior meatus showing the balloon
catheter exiting from the nasolacrimal duct. Note the length of the
catheter seen.
Figure 3. Manometer mounted on the inflation device to show the
pressure in atmospheres.
Figure 4. Endoscopic view of the inferior meatus showing the balloon
dilatation of the distal nasolacrimal duct. Note the inflated balloon and
compare it with deflated stage in Fig. 2.
Figure 5. Endoscopic view of the inferior meatus showing balloon
dilatation of the proximal nasolacrimal duct. Note that only the tip of
the catheter is visible at NLD. Compare this with the length of catheter
seen in Figs. 2 and 3.
Figure 6. Endoscopic view of the dilated nasolacrimal duct opening.
Note the silicone tube exiting the duct opening in inferior meatus.
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loss, risks of general anesthesia if used and scarring in exter-
nal DCR. The quest on this front has been to look into the fea-
sibility of using minimally invasive alternatives. With the
advent of balloons, several studies have looked at the effi-
cacy of using 3-mm balloon catheters in such cases.2–16 The
3 mm balloon has an outer diameter of 3 mm and length of
15 mm, and targets at dilating the distal and proximal
portions of nasolacrimal duct. The balloon dilatation likely
interferes with the inflammation–stenosis–obstruction–sta-
sis–infection cycle by restoring the anatomical patency.
A number of studies in the past have used the retrograde
approach of balloon dilatation that requires additional radio-
graphic control and multidisciplinary approach.2,7–10 In spite
of these guidance tools, there can sometimes be a proce-
dural failure because of the inability to catheterize the naso-
lacrimal duct. The success rates using retrograde approaches
have been reported to vary between 25% to as high as
90%.2,7–10 The authors of the current study, like many other
proponents of anterograde approach believe it to be muchsimpler with a short learning curve, can be performed by an
ophthalmologist alone without encountering technical
failures like inability to catheterize and is less expensive. At
the same time we also stress on the use of nasal endoscopic
guidance during the procedure since it ascertains an accurate
dilatation of nasolacrimal ducts and also allows visualization
of nasal cavity and inferior meatus for any pathology that
may occlude the outlet.
Perry et al.11 used dacryocystography to assess the post-
saccal stenosis and treated 15 partially obstructed nasolacri-
mal ducts in adults with balloon dilatation and intubation and
at 6 months follow up reported anatomical success rates of
73%. They subjectively assess the epiphora using the Munk
scale2 and reported the resolution of epiphora in 60% of
patients.
Kuchar et al.12 used transcanalicular endoscopes to aid in
the diagnosis of nasolacrimal duct obstructions and reported
an overall subjective success of 73% at one year after balloon
dilatation. The duration of epiphora in their study did not
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sented in the first six months following the procedure. It is
interesting to note that all patients selected in this study were
having complete nasolacrimal duct obstruction and 4 pa-
tients underwent laser canaliculoplasty for canalicular mem-
branous obstructions. In contrast our study focused only on
partial obstructions and excluded complete obstructions,
post-traumatic obstructions as well as canalicular stenosis
and obstructions. The authors of the current study concur
with Luchtenberg et al.13 that these excluded cases do not
do well with balloon dilatation.
In the largest study so far, Couch et al.14 studied 142 par-
tially obstructed nasolacrimal ducts at a mean follow up of
7.5 months, reported an overall improvement in epiphora in
90% of their patients with the complete resolution of epiph-
ora in 56%. Based on the substantial improvement of epiph-
ora in their large series, they recommended it as a procedure
of choice in patients with incomplete NLDO in the absence of
secondary causes of epiphora.
The long term effects of balloon dacryoplasty were stud-
ied by Konuk et al.15 in 99 eyes of 94 patients with a mean fol-
low up of 100 ± 38.4 months. The study subjects were a
mixture of common canalicular stenosis, proximal and distal
nasolacrimal duct obstructions. The overall long term success
rates were not encouraging except for partial distal NLDO
(73.3%), which made the authors recommend balloon dilata-
tion as an alternative for this subset only.
The use of silicone intubation along with a balloon dacryopl-
asty is not clear. Kashkouli et al5 retrospectively compared bal-
loon dilatation with intubation vs. intubation alone and
reported no statistical difference between groups (61% vs.
54%) in the outcomes at a mean follow up of 14.60 months.
However, it is important to note that this was not a randomized
study. Bleyen et al.16 conducted a similar study but was a
randomized control trial. They also did not find a significant
difference between groups (52% vs. 57%).
Complications of balloon dacryoplasty reported in the lit-
erature include intra-operative pain, headaches, nasal bleed,
blurred vision and iatrogenic false passages.2–16 The only ma-
jor complication reported was a single case of orbital emphy-
sema that was initiated with a forceful sneezing in a patient,
but was managed successfully by a conservative approach.17
This brief list of complications does not make balloon dac-
ryoplasty an unsafe procedure but helps the surgeon to coun-
sel the patient in a better manner.
In conclusion, balloon dacryoplasty represents a minimally
invasive technique which can be performed with satisfying re-
sults in adults with acquired partial nasolacrimal duct obstruc-
tions. The procedure appears to be safe, however, studieswith larger sample size and longer follow up are required
to conclusively prove or disprove its role in avoiding a
dacryocystorhinostomy.
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